SWX:NESN
SWX:NESNFood

Is Nestlé (SWX:NESN) Offering Value After Mixed Long Term Share Price Performance

If you are wondering whether Nestlé is still a solid long term hold or starting to look expensive at its current price, the key question is how today’s market value lines up with the fundamentals. The share price recently closed at CHF78.74, with a flat 7 day return of 0.0% and a small 30 day decline of 0.1%, while the 1 year return of 10.2% contrasts with a 3 year decline of 22.6% and a 5 year decline of 9.8%. Recent discussion around Nestlé has focused on how a global consumer staples...
SWX:COTN
SWX:COTNElectronic

Three European High Growth Tech Stocks To Watch

As the pan-European STOXX Europe 600 Index edges closer to record highs amid optimism about future earnings and economic prospects, investors are keenly observing the high-growth tech sector, which remains a focal point of innovation and potential. In such an environment, identifying promising stocks often involves looking for companies with robust growth trajectories and adaptability to evolving technological trends, making them standouts in a dynamic market landscape.
SWX:STMN
SWX:STMNMedical Equipment

3 European Stocks That May Be Trading Below Their Estimated Value

As the pan-European STOXX Europe 600 Index edged slightly higher in a holiday-shortened week, optimism about future earnings and economic conditions has kept investor sentiment buoyant. In this environment, identifying stocks that may be trading below their estimated value can offer potential opportunities for investors looking to capitalize on market inefficiencies.
SWX:ROG
SWX:ROGPharmaceuticals

Will FDA’s Rapid-Delivery Lunsumio VELO Approval Reshape Roche Holding's (SWX:ROG) High-Value Biologics Narrative?

Earlier this month, Genentech, a member of the Roche Group, received U.S. FDA accelerated approval for Lunsumio VELO, a subcutaneous formulation of mosunetuzumab for adults with relapsed or refractory follicular lymphoma after at least two prior systemic therapies, cutting administration time from hours to about one minute. This approval not only broadens Roche’s oncology offering but also highlights how treatment convenience and clinic efficiency are becoming core differentiators in cancer...
SWX:ALC
SWX:ALCMedical Equipment

Alcon (SWX:ALC): Reassessing Valuation After Recent Share Price Stabilisation

Alcon (SWX:ALC) has quietly outperformed the broader healthcare space over the past month, with shares climbing about 4% even as the stock remains down sharply year to date. See our latest analysis for Alcon. That recent 30 day share price return of 3.84% looks more like a stabilisation than a full reversal. The year to date share price is still down 16.42%, and the one year total shareholder return is negative but modestly positive over three years. If Alcon’s move has you reassessing the...
SWX:UBSG
SWX:UBSGCapital Markets

Is UBS Group (SWX:UBSG) Turning Job Cuts And Tech Centralization Into A Sharper Efficiency Story?

UBS Group AG recently outlined further Credit Suisse integration steps, including multi-wave job cuts through 2026 and leadership changes in operations and technology, with Group Technology set to report to incoming Group Chief Operating Officer Beatriz Martin from January 2026. By consolidating technology under the Group COO and emphasizing artificial intelligence and IT migration, UBS is signaling a push to streamline operations while completing the complex Credit Suisse integration. We’ll...
SWX:EPIC
SWX:EPICReal Estate

EPIC Suisse (SWX:EPIC): Valuation Check After CHF 70m Follow-On Equity Offering

EPIC Suisse (SWX:EPIC) has just raised CHF 70 million through a follow on equity offering at CHF 80 per share, a move that directly affects both its growth options and shareholder dilution. See our latest analysis for EPIC Suisse. The fresh capital raise comes on the back of a steady share price return so far this year and a much stronger 1 year total shareholder return of 11.57 percent, suggesting confidence in EPIC Suisse’s long term real estate strategy. If this equity deal has you...
SWX:HOLN
SWX:HOLNBasic Materials

Will Expanding ECOCycle® Recycling Capacity Across Europe Change Holcim's (SWX:HOLN) Narrative?

Holcim recently completed two acquisitions and agreed a third in demolition materials recycling across the UK, Germany and France, adding around 1.3 million tons of annual permitted processing capacity to accelerate its ECOCycle® circular construction platform in Europe. By linking these recycling businesses into its existing network, including prior UK and continental European deals, Holcim is deepening local access to circular construction services in major urban and infrastructure...
SWX:KNIN
SWX:KNINShipping

Is Kuehne and Nagel Fairly Priced After Recent 13.4% Share Price Rebound?

Wondering if Kuehne + Nagel International is quietly turning into a value opportunity, or if the recent interest is just noise? Let us unpack what the current share price is really telling you. After a rough stretch that still leaves the stock down 15.3% year to date and 10.5% over the last year, the shares have bounced with gains of 6.5% in the last week and 13.4% over the past month. Those moves come as investors refocus on global trade normalising, ongoing supply chain recalibration after...
SWX:PGHN
SWX:PGHNCapital Markets

Is Partners Group’s New AuM Data and 2026 Outlook Briefing Altering The Investment Case For Partners Group Holding (SWX:PGHN)?

Partners Group recently reported its Assets under Management as of 31 December 2025 and confirmed it will host a 2025 Business Update and 2026 Outlook presentation on 14 January 2026, offering fresh detail on its operations and plans. This combination of an AuM disclosure and upcoming outlook briefing gives investors a clearer window into how the firm is positioning its private-markets platform for the next phase of growth and product development. We’ll now explore how the latest AuM...